mepolizumab
SpainDrugs containing this active substance
-
It is used to treat severe eosinophilic asthma in adults, adolescents, and children aged 6 years and older. It is also used to treat chronic rhinosinusitis with nasal polyps, chronic obstructive pulmonary disease (COPD), eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (HES) in adults.
Form: solution for injection in pre-filled pen
Active substance Dosage mepolizumab Igual a 100 mg mg Manufacturer: Glaxosmithkline Trading Services Limited
-
It is used to treat severe asthma (specifically eosinophilic asthma), Eosinophilic Granulomatosis with Polyangiitis (EGPA), chronic rhinosinusitis with nasal polyps (CRSwNP), chronic obstructive pulmonary disease (COPD), and hypereosinophilic syndrome (HES).
Form: solution for injection in a pre-filled syringe
Active substance Dosage mepolizumab 100 mg Manufacturer: Glaxosmithkline Trading Services Limited
-
It is used to treat severe asthma in adults, adolescents, and children aged 6 years and older, specifically in cases of eosinophilic asthma (when there are too many eosinophils in the blood and lungs).
Form: solution for injection in a pre-filled syringe
Active substance Dosage mepolizumab 40 mg Manufacturer: Glaxosmithkline Trading Services Limited